Calidad de la información farmacoterapéutica dirigida a pacientes: caso práctico con los inhibidores de la bomba de protones

Robert Sabaté, L.; Palencia-Lefler Ors, Manuel; Juárez-Giménez, J.C.

Calidad de la información farmacoterapéutica dirigida a pacientes: caso práctico con los inhibidores de la bomba de protones

Citation

Robert Sabaté L, Palencia-Lefler M, Juárez-Giménez JC. Calidad de la información farmacoterapéutica dirigida a pacientes: caso práctico con los inhibidores de la bomba de protones. El Farmacéutico Hospitales. 2020;218:15-22.

Abstract

The aim of this study is to analyse the quality of written information that may be received by patients within our setting in relation to PPIs. The following have been included: package inserts; information from databases; and reference sources for information on medications targeted at the public audience, as well as news and documents obtained on carrying out an internet search. The quality has been analysed using the DISCERN and EQIP instruments, as well as HON criteria. The results indicate that information obtained from official sources or reference sources is of superior quality with respect to information obtained from an internet search, or where information comes from press news sources. On the basis of the analysis, recommendations have been proposed to improve the quality, to be included in any form of patient information: bibliography and additional sources; treatment alternatives; impact on quality of life; and supporting information in case of any doubts. It is important that patients receive information that is of high quality in order to improve literacy levels, promote safe and effective use of medications, and to enable patients to make better informed treatment decisions.